Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Double Blind Study to Evaluate Safety and Immunogenicity of Meningococcal Meningitis Serogroups A, C, Y & W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NmVac4-A/C/Y/W-135-DT™) Compared With a Licensed Vaccine

NCT01897402 is registered in ClinicalTrials.gov with JN-International Medical Corporation as lead sponsor.

NCT NCT01897402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01897402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Double Blind Study to Evaluate Safety and Immunogenicity of Meningococcal Meningitis Serogroups A, C, Y & W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NmVac4-A/C/Y/W-135-DT™) Compared With a Licensed Vaccine
Lead sponsor
JN-International Medical Corporation
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
December 31, 2014
Enrollment
525 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal infections, meningococcal meningitis